Janet Dillione insider trades

Open-market stock purchases and sales by Janet Dillione, Director at CorMedix Inc, from SEC Form 4 filings since Jun 30, 2010.

Track record: 75% of 4 scored buys are up 5% or more since purchase, averaging +71%.

Recent trades

DateStockTradeValue
Jan 26, 2026CRMD CorMedix IncBought (not open market)—
Jan 21, 2026CRMD CorMedix IncSold$68.8K
Dec 9, 2025CRMD CorMedix IncSold$408K
Dec 9, 2025CRMD CorMedix IncBought (not open market)—
Dec 9, 2025CRMD CorMedix IncBought (not open market)—
Dec 2, 2025CRMD CorMedix IncSold$467K
Dec 2, 2025CRMD CorMedix IncBought (not open market)—
Dec 2, 2025CRMD CorMedix IncBought (not open market)—
Dec 2, 2025CRMD CorMedix IncBought (not open market)—
Nov 24, 2025CRMD CorMedix IncSold$262K
Nov 24, 2025CRMD CorMedix IncBought (not open market)—
Nov 24, 2025CRMD CorMedix IncBought (not open market)—
Nov 24, 2025CRMD CorMedix IncBought (not open market)—
Nov 24, 2025CRMD CorMedix IncBought (not open market)—
Nov 14, 2025CRMD CorMedix IncSold$343K

Companies traded

  • CRMD CorMedix Inc: 9 buys, 5 sales, last Jan 26, 2026
  • NUAN Nuance Communications, Inc: 6 sales, last Dec 6, 2013

Get free alerts when Janet Dillione files a new trade →